Cardio-oncology: a myriad of relationships between cardiovascular disease and cancer

Y Wang, Y Wang, X Han, J Sun, C Li… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular disease (CVD) and cancer are the leading causes of death worldwide. With
an increasing number of the elderly population, and early cancer screening and treatment …

Calcium permeable channels in cancer hallmarks

S Tajada, C Villalobos - Frontiers in pharmacology, 2020 - frontiersin.org
Cancer, the second cause of death worldwide, is characterized by several common criteria,
known as the “cancer hallmarks” such as unrestrained cell proliferation, cell death …

The use of antihypertensive drugs as coadjuvant therapy in cancer

JA Carlos-Escalante, M de Jesus-Sanchez… - Frontiers in …, 2021 - frontiersin.org
Cancer is a complex group of diseases that constitute the second largest cause of mortality
worldwide. The development of new drugs for treating this disease is a long and costly …

[HTML][HTML] Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis

Y Xie, P Xu, M Wang, Y Zheng, T Tian, S Yang… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Several studies have indicated that the use of antihypertensive medications may influence
the incidence of bladder/kidney cancer, with some scholars refuting any such association …

Onco-hypertension: an emerging specialty

P Gudsoorkar, R Ruf, H Adnani, K Safdar… - Advances in Chronic …, 2021 - Elsevier
Cancer is one of the leading causes of death worldwide. With the introduction of newer
chemotherapeutic agents, targeted therapies, and immunotherapy, the prognosis and …

Intriguing relationship between antihypertensive therapy and cancer

M Tadic, C Cuspidi, E Belyavskiy, G Grassi - Pharmacological Research, 2019 - Elsevier
Arterial hypertension is the most frequent cardiovascular risk factor in the cancer patients.
Anti-cancer therapy very often induces arterial hypertension and the treatment with …

Evaluating risk factors for lung cancer among never-smoking individuals using two Australian studies

ES Cheng, MF Weber, J Steinberg, K Canfell… - Journal of Cancer …, 2022 - Springer
Purpose Lung cancer (LC) in never-smoking individuals would rank as Australia's eighth
most deadly cancer, yet risk factors remain uncertain. We investigated demographic, lifestyle …

Systematic review of Mendelian randomization studies on antihypertensive drugs

B Fan, J Zhang, JV Zhao - BMC medicine, 2024 - Springer
Abstract Background We systematically reviewed Mendelian randomization (MR) studies
and summarized evidence on the potential effects of different antihypertensive drugs on …

Angiotensin converting enzyme inhibitors and risk of lung cancer: a systematic review and meta-analysis

M Batais, T Almigbal, K Alotaibi, A Alodhayani… - Medicine, 2021 - journals.lww.com
Background: We performed a meta-analysis to determine whether a consistent relationship
exists between the use of angiotensin converting enzyme inhibitors (ACEIs) and the risk of …

Calcium channel blockers and the risk for lung cancer: a population-based nested case-control study

V Rotshild, L Azoulay, I Feldhamer… - Annals of …, 2019 - journals.sagepub.com
Background: It has been suggested that calcium channel blockers (CCBs) may increase the
risk of lung cancer; however, current evidence is conflicting and limited. Objective …